Company intelligence / Profile preview

BioMixing

Seville, Andalusia, Spain

Ownership: Private
Development stage: Other

Overview

BioMixing has developed a patented agitation-aeration system that significantly improves efficiency in fermenters and bioreactors. Their technology reduces processing times by up to 50%, energy consumption by up to 40%, and minimizes shear damage, enabling more efficient production of biologics, vaccines, cultured meat, biofertilizers, cosmetics ingredients, and biofuels. The platform is used both in new bioreactors ("Biomixing Inside") or as retrofit kits for existing systems[1][2][3][4].

Industry: Non-Drug Biotech

Partnerships

MassChallenge Switzerland (grant/investment)StartBEC Technological Support Program (investor)Collaborations with Spanish private research organizationsIn discussions with several international bioreactor manufacturers for integration/supply agreements

Beyond the preview

Go deeper on BioMixing.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioMixing.

Explore the full profile